SYDNEY (April 3): A man in the Australian state of Victoria has been hospitalized for a blood clot after receiving the AstraZeneca COVID-19 vaccine, Chinese news agency Xinhua reported.
The 44-year-old man received the vaccine on March 22 and was hospitalized at Box Hill Hospital in Melbourne days later with fever and abdominal pain. He was found to have abdominal clots with a low platelet count, according to a Guardian report on Saturday.
This is the first case of a blood clot recorded in Australia after previous cases in Europe caused several countries to temporarily suspend the use of the AstraZeneca vaccine.
The Therapeutic Commodities Administration (TGA), Australia’s regulatory authority for therapeutic products, said it was investigating “this rare case”.
TGA also works closely with international regulators and is attending meetings with the UK Medicines Control Agency (MHRA) and the European Medicines Agency to discuss these rare cases in the coming days.
The regulatory body also defended the vaccine, saying that at this stage no cause-and-effect relationship had been established between the COVID-19 vaccine and this case or those reported worldwide. The benefits of a COVID-19 vaccine continue to outweigh any risks.
According to the latest Australian Ministry of Health statistics, 541,761 vaccine doses have been given as of March 28th.